-
公开(公告)号:EP1482975B1
公开(公告)日:2006-12-13
申请号:EP03702560.8
申请日:2003-01-29
申请人: Vlaams Interuniversitair Instituut voor Biotechnologie vzw. , Thromb-X , K.U. Leuven Research and Development
IPC分类号: A61K45/00 , A61K41/00 , A61K39/395
CPC分类号: C12N15/113 , A61K31/00 , A61K38/1709 , A61K2039/505 , C07K14/4702 , C07K16/22 , C12N15/1136 , C12N2310/12 , C12N2310/13
摘要: The present invention is concerned with compositions for use in the medical art. More particularly the invention relates to uses of inhibitors against hypoxia-induced genes for the manufacture of a medicament to prevent and/or to suppress post-operative/post-wounding adhesions formation. Post-operative adhesions are an unwanted result from surgery and are a major source of postoperative morbidity and mortality. The invention applies to human and veterinary applications. To date, no single therapeutic approach has proven universally effective in preventing formation of post-operative adhesions formations.
-
公开(公告)号:EP1482975A2
公开(公告)日:2004-12-08
申请号:EP03702560.8
申请日:2003-01-29
申请人: Vlaams Interuniversitair Instituut voor Biotechnologie vzw. , Thromb-X , K.U. Leuven Research and Development
IPC分类号: A61K45/00 , A61K41/00 , A61K39/395
CPC分类号: C12N15/113 , A61K31/00 , A61K38/1709 , A61K2039/505 , C07K14/4702 , C07K16/22 , C12N15/1136 , C12N2310/12 , C12N2310/13
摘要: The present invention is concerned with compositions for use in the medical art. More particularly the invention relates to uses of inhibitors against hypoxia-induced genes for the manufacture of a medicament to prevent and/or to suppress post-operative/post-wounding adhesions formation. Post-operative adhesions are an unwanted result from surgery and are a major source of postoperative morbidity and mortality. The invention applies to human and veterinary applications. To date, no single therapeutic approach has proven universally effective in preventing formation of post-operative adhesions formations.
-